Evaluation of the hepatoprotective activity of standardized ethanolic extract of Curcuma xanthorrhiza Roxb

Journal of Medicinal Plants Research

Volumn 4, Issue 23, 2010, Pages 2512-2517

  Devaraj, Sutha ^a   Ismail, Sabariah ^a   Ramanathan, Surash ^a   Marimuthu, Santhini ^a   Fei, Yam Mun ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Curcuma xanthorrhiza; Ethanol; Hepatoprotective activity; Serum enzyme

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CURCUMA XANTHORRHIZA EXTRACT; LIVER ENZYME; LIVER PROTECTIVE AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CURCUMA LONGA; CURCUMA XANTHORRHIZA; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; TREATMENT RESPONSE;

CURCUMA XANTHORRHIZA; RATTUS;

EID: 78651464564     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: 10.5897/jmpr10.453     Document Type: Article

References (26)

1. Caballeria J, Baraona E, Lieber CS (1987). The contribution of the stomach to ethanol oxidation in the rat. Life Sciences 41(8): 1021-1027.
2. Chenoweth MB, Hake CL (1962). The smaller halogenated aliphatic hydrocarbons. Annu. Rev. Pharmacol 2:363-398.
3. Conda de la Rosa L, Moshage H, Nieto N (2008). Hepatocyte oxidant stress and alcoholic liver disease. Revista Espanalo de Enfermedades Digestivas 100: 156-163.
4. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D (1987). Oxygen radicals and human disease. Annals Int. Med. 107(5):526-545.
5. Devaraj S, Esfahani AS, Ismail S, Ramanthan S, Yam MF (2010). Evaluation of the Antinociceptive Activity and Acute Oral Toxicity of Standardized Ethanolic Extract of the Rhizome of Curcuma xanthorrhiza Roxb. Molecules 15(4): 2925-2934.
6. Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995). Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5: 259-274.
7. Gaw A, Cowan RA, O'Reilly DST, Stewart MJ, Shephed JS (1998). Cinical Biochemistry. Churchill Livingstone, Edinburg. 22:51-65
8. Hwang JK, Shim JS (2000). Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. Fitoterapia, 120-749.
9. Israel Y, Videla L, Bernstein J (1975). Liver hypermetabolic state after chronic ethanol consumption: Hormonal interrelations and pathogenic implications. Federation Proceedings 34(11): 2052-2059.
10. James LP, Mayeux PR, Hinson JA (2003). Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos., 31 (12): 1499-1506.
11. Khanal T, Choi JH, Hwang YP, Chung YC, Jeo HG (2009). Saponins isolated from the root of Platycodon grandiflorum protect against acute ethanol-induced hepatotoxicity in mice. Food Chem. Toxicol., 47:530-535.
12. Lelbach WK (1975). Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Annals of the New York Academy of Sciences 252: 85-105.
13. Morgan MY, Sherlock S, Scheuer PJ (1978). Acute cholestasis, hepatic failure, and fatty liver in the alcoholic. Scandinavian J. Gastroenterol., 13(3): 299-303.
14. Nyblom H, Berggren U, Balldin J, Olsson R (2004). High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol 39 (4): 336-339.
15. Okuda K (1997). Hepatocellular carcinoma: clinical pathological aspects. J. Gastroenterol. Hepatol., 2(9-10): S314-S318.
16. Orhan DD, Aslant M, Aktay G, Ergun E, Yesilada E, Ergun F (2003). Evaluation of hepatoprotective effect of Gentian olivieri herbs on subacute administration and isolation of active principle. Life Sci., 72: 2273-2283.
17. Pantheghini M (1990). Aspartate aminotransferase isoenzymes. Clin. Biochem., 23 (4):311-319.
18. Ryan CJ, Aslam M, Courtney JM (1990). Transferance of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange. Biomat Artif Cells Artif Organs 18:477-482.
19. Salaspuro MP, Shaw S, Jayatilleke E, Ross, WA, Lieber CS (1981). Attenuation of the ethanol-induced hepatic redox change after chronic alcohol consumption in baboons: Metabolic consequences in vivo and in vitro. Hepatology 1(1): 33-38.
20. Sallie R, Tredger JM, William R (1991). Drugs and the liver. Biopharmaceut Drug Diposit., 12:251-259.
21. Sears B (2005). In the Anti-Inflammation Zone - Reversing the Silent Epidemic That's Destroying Our Health. In: HarperCollins Publishers, New York, NY, USA. pp. 75-87.
22. Seong HK, Kyoung OH, Won YC, Jae KH, Kwang KP (2004). Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol. Appl. Pharmacol., 196: 346-355.
23. Shyamal S, Latha PG, Shine VJ, Suja SR, Rajasekharan S, Devi TG (2006). Hepatoprotective effects of Pittosporum neelgherrense Wight & Arn, a popular Indian ethnomedicine. J. Ethnopharmacol., 107:151-155.
24. Vallee BL, Bazzone TJ (1983). Isozymes of human liver alcohol dehydrogenase. Isozymes: Current Topics in Biological Medical Research 8: 219-244.
25. Zeng T, Zhang CL, Zhu ZP, Yu LH, Zhao XL, Xie KQ (2008). Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology 252: 86-91.
26. Zhao J, Chen H, Li Y (2008). Protective effect of bicyclol on acute alcohol-induced liver injury in mice. Euro. J. Pharmacol., 586: 322-331.